Bio-Techne Corp (TECH)
76.87
+1.27
(+1.68%)
USD |
NASDAQ |
May 03, 10:01
Bio-Techne Max Drawdown (5Y): 60.51% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
April 30, 2024 | 60.51% |
March 31, 2024 | 60.51% |
February 29, 2024 | 60.51% |
January 31, 2024 | 60.51% |
December 31, 2023 | 60.51% |
November 30, 2023 | 60.51% |
October 31, 2023 | 59.16% |
September 30, 2023 | 49.53% |
August 31, 2023 | 47.51% |
July 31, 2023 | 47.51% |
June 30, 2023 | 47.51% |
May 31, 2023 | 47.51% |
April 30, 2023 | 47.51% |
March 31, 2023 | 47.51% |
February 28, 2023 | 47.51% |
January 31, 2023 | 47.51% |
December 31, 2022 | 47.51% |
November 30, 2022 | 47.51% |
October 31, 2022 | 47.51% |
September 30, 2022 | 47.41% |
August 31, 2022 | 39.99% |
July 31, 2022 | 39.99% |
June 30, 2022 | 39.99% |
May 31, 2022 | 37.07% |
April 30, 2022 | 34.84% |
Date | Value |
---|---|
March 31, 2022 | 34.84% |
February 28, 2022 | 34.84% |
January 31, 2022 | 34.84% |
December 31, 2021 | 34.84% |
November 30, 2021 | 34.84% |
October 31, 2021 | 34.84% |
September 30, 2021 | 34.84% |
August 31, 2021 | 34.84% |
July 31, 2021 | 34.84% |
June 30, 2021 | 34.84% |
May 31, 2021 | 34.84% |
April 30, 2021 | 34.84% |
March 31, 2021 | 34.84% |
February 28, 2021 | 34.84% |
January 31, 2021 | 34.84% |
December 31, 2020 | 34.84% |
November 30, 2020 | 34.84% |
October 31, 2020 | 34.84% |
September 30, 2020 | 34.84% |
August 31, 2020 | 34.84% |
July 31, 2020 | 34.84% |
June 30, 2020 | 34.84% |
May 31, 2020 | 34.84% |
April 30, 2020 | 34.84% |
March 31, 2020 | 34.84% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
34.84%
Minimum
May 2019
60.51%
Maximum
Nov 2023
40.88%
Average
34.84%
Median
May 2019
Max Drawdown (5Y) Benchmarks
Agenus Inc | 96.18% |
BioCryst Pharmaceuticals Inc | 90.33% |
AIM ImmunoTech Inc | 99.76% |
Protalix BioTherapeutics Inc | 94.35% |
Armata Pharmaceuticals Inc | 99.87% |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | -11.01 |
Beta (5Y) | 1.233 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 34.56% |
Historical Sharpe Ratio (5Y) | 0.0791 |
Historical Sortino (5Y) | 0.1511 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 14.33% |